Since 12th January 2018, Ministry of Agriculture of People’s Republic of China has stopped accepting the application for registered number of approval for Olaquindox, Arsanilic acid, Roxarsone, including related crude drug and drug product. After 1st May 2018, the production of these kinds of drug will be stopped in China, and the registered number of approval of related companies will be canceled. The product produced by 30th April 2018 can be circulated and used by 30th April 2019. After 1st May 2019, the operation and use of these drugs will be stopped in China.
(Minister of Agriculture of the People’s Republic of China)
At Asian Agribusiness Consulting our mission is the promotion and development of agribusiness across Asia. We provide specialist research and consulting services for our clients who have intentions of ratcheting up their presence in Asia be they start-ups companies to blue-chip companies.
AAC provides agricultural consulting and recruitment...
On friday AAC attended the Barossa party at the glamorous...
Give us a call at
(86) 10 65919042
Email us at
This email address is being protected from spambots. You need JavaScript enabled to view it.